Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Apr;160(5):1447-1451.
doi: 10.1053/j.gastro.2020.12.042. Epub 2020 Dec 30.

COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions

Ryan C Ungaro  1 , Michael D Kappelman  2 , David T Rubin  3 , Jean-Frederic Colombel  1
Affiliations
Comment

COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions

Ryan C Ungaro et al. Gastroenterology. 2021 Apr.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Coronavirus disease (COVID-19) – World Health Organization. www.who.int/emergencies/diseases/novel-coronavirus-2019 Available:
    1. Rubin D.T., Abreu M.T., Rai V., et al. Management of patients with Crohn’s disease and ulcerative colitis during the coronavirus disease-2019 pandemic: results of an international meeting. Gastroenterology. 2020;159:6–13.e6. - PMC - PubMed
    1. SECURE-IBD Database SECURE-IBD Database. https://covidibd.org/ Available:
    1. Brenner E.J., Ungaro R.C., Gearry R.B., et al. Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 Outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology. 2020;159:481–491.e3. - PMC - PubMed
    1. Ungaro R.C., Brenner E.J., Gearry R.B., et al. Effect of IBD medications on COVID-19 outcomes: results from an international registry. Gut. Oct 20, 2020 [Epub ahead of print] - PMC - PubMed